Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Peter C. Enzinger | Researchclopedia

Back to researchers

Peter C. Enzinger

Dana-Farber Cancer Institute

274

Works

24,847

Citations

62

h-index

126

i10-index

Research Topics

Gastric Cancer Management and Outcomes Esophageal Cancer Research and Treatment Colorectal Cancer Treatments and Studies

Affiliations

Broad Institute2012–2012

Boston University2023–2023

Brigham and Women's Hospital2003–2025

Beth Israel Deaconess Medical Center2006–2009

Memorial Sloan Kettering Cancer Center1998–1999

Top Works

Esophageal Cancer

Peter C. Enzinger,Robert J. Mayer

20032,510 citations

Cancer Immunotherapy and Biomarkers

Pancreatic and Hepatic Oncology Research

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Charles S. Fuchs,Toshihiko Doi,et al.

20181,796 citations

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani,Thomas A. D’Amico,et al.

20221,642 citations

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun,Lin Shen,et al.

20211,515 citations

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson,Alan P. Venook,et al.

20171,366 citations

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Takashi Kojima,Manish A. Shah,et al.

20201,152 citations

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Kohei Shitara,Eric Van Cutsem,et al.

20201,097 citations

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani,Thomas A. D’Amico,et al.

20191,085 citations

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

Kohei Shitara,Florian Lordick,et al.

2023645 citations